clinical trials

News

Keros pulls study of Winrevair rival after safety signal

Adverse events have led Keros to abandon a phase 2 trial of pulmonary arterial hypertension drug cibotacept, a would-be rival to MSD's Winrevair.

News

Sling shoots at thyroid eye disease with its oral therapy

Amgen's thyroid eye disease blockbuster Tepezza, given by infusion, is facing competition from an oral alternative from Sling Therapeutics.

News

Bayer gains ground in two-fronted Parkinson's offensive

Bayer's cell therapy for Parkinson's disease is on the brink of a phase 3 trial, while its gene therapy has started phase 2 testing.

R&D

The intricacies of effectively transitioning active clinical...

European Union lawmakers designed EU Clinical Trial Regulation 536/2014 to heighten interest within the healthcare industry for planning and conducting clinical trials in the

News

combination of directions for booted feet, two arrows

J&J says Rybrevant combo has survival edge over Tagrisso

Rybrevant plus Lazcluze extended median OS by more than a year compared to Tagrisso in the MARIPOSA trial in treatment-naive, EGFR-mutated NSCLC.

News

Denali slides after ALS drug flunks clinical test

Another clinical trial setback disappoints the ALS patient community, this time involving Denali's eIF2B agonist DNL343.

Keros pulls study of Winrevair rival after safety signal

Sling shoots at thyroid eye disease with its oral therapy

Bayer gains ground in two-fronted Parkinson's offensive

The intricacies of effectively transitioning active clinical...

J&J says Rybrevant combo has survival edge over Tagrisso

Denali slides after ALS drug flunks clinical test

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks